Description
Paxista is an investigational antiviral therapy medicine with active ingredients Nirmatrelvir 150 MG and Ritonavir 100 MG approved for emergency use. The drug is indicated for treating mild-to-moderate coronavirus disease in adults and pediatric patients (aged >12 years and weight>40 kg) testing positive for SARS-CoV-2 virus, at high risk of progression, including hospitalization or death.
Ritonavir is co-administered with Nirmatrelvir as it acts as a pharmacokinetic enhancer resulting in higher systemic concentrations and a longer half-life of Nirmatrelvir, thereby supporting a twice-daily administration regimen.
Side effects
Tell your doctor if you have any liver problems like loss of appetite, yellowing of skin, whites of eyes (jaundice), dark-colored urine, pale colored stools, itchy skin, stomach or abdomen pain.
· If you have untreated HIV infection the Paxista may reduce the effectiveness of some HIV medicines.
· Altered sense of taste
· Diarrhoea
· High blood pressure
· Muscle aches
Everybody using Paxista would not experience all the side effects. There might be many other serious and unexpected side effects of the medicine. However, if the side effects persist for long or bother your health seek medical help immediately.
